EbeneMagazine – Chinese Covid-19 vaccine triggers immune response

We attach great importance to the protection of your personal data so that you can know and fully understand the rights you enjoy, we inform you about the principle of transparency that governs the processing of your personal data, to be respected, on the new versions of the privacy policy and the privacy policy The use of cookies and automatic registration have existed for 24 years

In order to improve the functionality of our website, increase the relevance of information content and optimize ad targeting, we collect anonymous technical information about you, in particular by using the tools of our partners. the process of processing personal data is detailed in the data protection regulation The technologies with which we do this are described in detail in the cookie policy and automatic registration

By clicking on “Accept and close”, you accept that your personal data can be used for the purposes described above

You can change your selection and withdraw your consent by other means specified in the privacy policy

While a Covid-19 vaccine candidate is being tested on volunteers in China, scientists from Chinese biopharmaceutical company Sinovac Biotech point out that even at this stage of early clinical trials, a rapid immune response is triggered, reports the medium term. The Infectious Diseases of the Lancet>

A candidate vaccine against Covid-19, developed as part of a study in volunteers by the Chinese biopharmaceutical company Sinovac Biotech, has demonstrated its safety and its ability to elicit a rapid immune response. Reviews of initial and interim clinical trials were published in The Lancet Publication of the Journal of Infectious Diseases

Antibody levels in the volunteers were lower than in people who had recovered from Covid-19, but that did not affect the vaccine’s ability to protect the human body from the virus, according to studies known as CoronaVac, it was tested on over 700 healthy adults between the ages of 18 and 59

Participants were injected with two doses of the vaccine 14 days apart. The results obtained demonstrate the efficacy of the product and its usefulness for emergency treatment during the pandemic, according to one of the authors of the scientific article, Fengcai Zhu

He said that to determine the duration of immunity after vaccination, further studies should be done

The vaccine candidate is now in the third phase of clinical trials to confirm its efficacy

By clicking on “Publish”, you agree that the personal data of your Facebook account will be used to give you the opportunity to comment on the content published on our site from your account. The personal processing process The data is described in detail in the data protection legislation

We are committed to protecting your personal information and have updated our privacy policy to comply with the General Data Protection Regulation (GDPR), a new EU regulation that entered into force on December 25 and entered into force in May 2018

Please see our privacy policy, it contains details on the types of data we collect, how we use it and your privacy rights

Since you have already shared your personal information with us when creating your personal account, please check the box below to continue using it:

If you do not want us to further process your data, please click here to delete your account

If you have any questions or concerns about our privacy policy, please contact privacy @ sputniknewscom

Registering and identifying you on Sputnik’s websites through one of your social media accounts indicates your acceptance of these rules.

You agree to speak in relation to the other speakers, readers and people mentioned in the articles

The administration reserves the right to remove comments published in languages ​​other than the main content of the article.

Comments entered by the user can be edited in all language versions of sputniknews-Sitecom

The administration reserves the right to block the user’s access to the site or to cancel his account without notice if the user violates the rules to write comments or acknowledge actions taken by the user for them. signs of such a violation

The user can start the procedure for restoring his / her account / unblocking access by writing a letter to the following e-mail address: The letter must contain: Moderatorde @ sputniknewscom

If the moderators think it is possible to restore / unlock the account, it will be

In the event of repeated violations of the rules and repeated blocking, the user’s access cannot be restored. In this case, the block is permanent